$BUDZ
WEED, INC. Stock $budz

$budz Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000109690624000701 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$0.00	$0.00	$0.00
YoY Change		-100.0%
Gross Profit	$0.00	$0.00	$0.00
YoY Change		-100.0%
Gross Profit Margin
Selling, General & Admin	$161.8K	$195.0K	$718.2K
YoY Change	1.18%	-26.34%	-48.48%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.071K	-$7.610K	$49.79K
YoY Change	-75.64%	-128.85%	-53.08%
% of Gross Profit
Operating Expenses	$170.1K	$191.7K	$770.6K
YoY Change	-7.53%	-34.15%	-48.81%
Operating Profit	-$170.1K	-$191.7K	-$770.6K
YoY Change	-7.53%	-33.65%	-48.81%
Interest Expense	$599.00	$320.00	$45.37K
YoY Change	-95.43%	-101.55%	-61.26%
% of Operating Profit
Other Income/Expense, Net	-$599.00	-$203.0K	$203.0K
YoY Change		9003.59%	28135.05%
Pretax Income	-$170.7K	-$394.4K	-$30.58K
YoY Change	-13.38%	-53.95%	-98.0%
Income Tax	$0.00	$980.00	$980.00
% Of Pretax Income
Net Earnings	-$170.7K	-$395.3K	-$31.56K
YoY Change	-13.38%	-53.84%	-97.93%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	123.5M shares	123.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$102.7K	$290.4K	$290.4K
YoY Change	7.26%	-8.05%	-8.05%
Cash & Equivalents	$102.7K	$290.4K
Short-Term Investments
Other Short-Term Assets	$4.439K	$4.855K	$24.62K
YoY Change	13.47%	199.14%	-0.04%
Inventory
Prepaid Expenses	$21.44K	$24.62K
Receivables	$4.440K	$4.860K	$4.860K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$128.6K	$319.9K	$319.9K
YoY Change	7.63%	-6.49%	-6.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$511.3K	$516.3K	$548.0K
YoY Change	-57.32%	-57.29%	-56.26%
Goodwill		$0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$575.2K	$584.2K	$584.2K
YoY Change	-54.96%	-54.78%	-54.78%
TOTAL ASSETS
Total Short-Term Assets	$128.6K	$319.9K	$319.9K
Total Long-Term Assets	$575.2K	$584.2K	$584.2K
Total Assets	$703.8K	$904.1K	$904.1K
YoY Change	-49.61%	-44.67%	-44.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$188.8K	$183.6K	$183.6K
YoY Change	15.21%	-3.27%	-3.27%
Accrued Expenses	$71.10K	$64.78K	$327.7K
YoY Change	56.33%	53.48%	-41.82%
Deferred Revenue
YoY Change
Short-Term Debt	$129.3K	$136.7K	$136.7K
YoY Change	-80.98%	-80.75%	-80.75%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$596.3K	$648.8K	$648.8K
YoY Change	-57.27%	-55.69%	-55.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$596.3K	$648.8K	$648.8K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$596.3K	$648.8K	$648.8K
YoY Change	-57.27%	-55.69%	-55.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$84.56M	-$84.39M
YoY Change	0.01%	0.04%
Common Stock	$123.5K	$123.5K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$107.5K	$255.3K	$255.3K
YoY Change
Total Liabilities & Shareholders Equity	$703.8K	$904.1K	$904.1K
YoY Change	-49.61%	-44.67%	-44.67%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$170.7K	-$395.3K	-$31.56K
YoY Change	-13.38%	-53.84%	-97.93%
Depreciation, Depletion And Amortization	$5.071K	-$7.610K	$49.79K
YoY Change	-75.64%	-128.85%	-53.08%
Cash From Operating Activities	-$177.7K	-$344.1K	-$1.074M
YoY Change	0.31%	90.87%	32.12%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$10.00K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities		$1.070K	$1.641M
YoY Change			30.55%
Cash From Investing Activities	$0.00	$1.070K	$1.631M
YoY Change	-100.0%		29.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$10.00K	-17.98K	-$588.0K
YoY Change	-69.5%	-55.03%	295.5%
NET CHANGE
Cash From Operating Activities	-$177.7K	-344.1K	-$1.074M
Cash From Investing Activities	$0.00	1.070K	$1.631M
Cash From Financing Activities	-$10.00K	-17.98K	-$588.0K
Net Change In Cash	-$187.7K	-361.0K	-$30.99K
YoY Change	-14.65%	63.9%	-110.49%
FREE CASH FLOW
Cash From Operating Activities	-$177.7K	-$344.1K	-$1.074M
Capital Expenditures	$0.00	$0.00	$10.00K
Free Cash Flow	-$177.7K	-$344.1K	-$1.084M
YoY Change	-5.05%	90.87%	33.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001393772
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123482685	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123482685	shares
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1505274	usd
CY2022	us-gaap	Payments To Acquire Oil And Gas Property PaymentsToAcquireOilAndGasProperty	0	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-53727
CY2023	dei	Entity Registrant Name EntityRegistrantName	WEED, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0452269
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4920 N. Post Trail
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Tucson
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85750
CY2023	dei	City Area Code CityAreaCode	520
CY2023	dei	Local Phone Number LocalPhoneNumber	818-8582
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	4248961	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	123482685	shares
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2023	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2023	dei	Auditor Location AuditorLocation	The Woodlands, Texas
CY2023Q4	us-gaap	Cash Cash	290409	usd
CY2022Q4	us-gaap	Cash Cash	315826	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24622	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24626	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4855	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1623	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	319886	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	342075	usd
CY2023Q4	us-gaap	Land Land	258319	usd
CY2022Q4	us-gaap	Land Land	372069	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	218681	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1109931	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	147771	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	137772	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	624771	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1619772	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	108431	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	410942	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	516340	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1208830	usd
CY2023Q4	budz	Finite Lived License FiniteLivedLicense	667	usd
CY2022Q4	budz	Finite Lived License FiniteLivedLicense	667	usd
CY2023Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	50000	usd
CY2022Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	50000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50667	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50667	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14484	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11884	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	36183	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	38783	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31653	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	44130	usd
CY2023Q4	us-gaap	Assets Assets	904062	usd
CY2022Q4	us-gaap	Assets Assets	1633818	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	183565	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	189779	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	64778	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42206	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	182500	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	434750	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	13000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	42266	usd
CY2023Q4	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	133073	usd
CY2022Q4	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	706507	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2023Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	35800	usd
CY2022Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31653	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44130	usd
CY2023Q4	budz	Due To Officers Or Stockholders Current1 DueToOfficersOrStockholdersCurrent1	723	usd
CY2022Q4	budz	Due To Officers Or Stockholders Current1 DueToOfficersOrStockholdersCurrent1	723	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	648753	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1464022	usd
CY2023Q4	us-gaap	Liabilities Liabilities	648753	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1464022	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123482685	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123482685	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	123483	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	123483	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83818351	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83796857	usd
CY2023Q4	budz	Subscription Payable SubscriptionPayable	701250	usd
CY2022Q4	budz	Subscription Payable SubscriptionPayable	611250	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84392563	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84361006	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-4788	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-788	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	255309	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	169796	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	904062	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1633818	usd
CY2023	us-gaap	Revenues Revenues	0	usd
CY2022	us-gaap	Revenues Revenues	0	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2023	us-gaap	Gross Profit GrossProfit	0	usd
CY2022	us-gaap	Gross Profit GrossProfit	0	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	394617	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	567159	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	323559	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	826689	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52392	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	111426	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	770568	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1505274	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-770568	usd
CY2023	us-gaap	Interest Expense InterestExpense	45374	usd
CY2022	us-gaap	Interest Expense InterestExpense	117124	usd
CY2023	us-gaap	Other Expenses OtherExpenses	203010	usd
CY2022	us-gaap	Other Expenses OtherExpenses	719	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	544761	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	988375	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	639773	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	739991	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-22831	usd
CY2023	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	-30577	usd
CY2022	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	-1528105	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	980	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-31557	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1528105	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5576	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-777	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25981	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1528882	usd
CY2023	budz	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	123709123	shares
CY2022	budz	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	122076877	shares
CY2023	budz	Basic And Diluted Earnings Per Share BasicAndDilutedEarningsPerShare	-0.0003
CY2022	budz	Basic And Diluted Earnings Per Share BasicAndDilutedEarningsPerShare	-0.013
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	617500	usd
CY2022	budz	Common Stock Sold For Cash Amount CommonStockSoldForCashAmount	40000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	813600	usd
CY2022	budz	Stock Issuance For Acquisition Of Hempriical Genetics Amount StockIssuanceForAcquisitionOfHempriicalGeneticsAmount	194302	usd
CY2022	budz	Imputed Interest On Loans ImputedInterestOnLoans	31722	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1528105	usd
CY2022	budz	Other Comprehensive Income Net OtherComprehensiveIncomeNet	777	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	169796	usd
CY2023	budz	Common Stock Sold For Cash CommonStockSoldForCash	0	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	90000	usd
CY2023	budz	Imputed Interest On Loans ImputedInterestOnLoans	21494	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-31557	usd
CY2023	budz	Other Comprehensive Income Net OtherComprehensiveIncomeNet	5576	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	255309	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-31557	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1528105	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52392	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	111426	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	14546	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	27845	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	988375	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	639773	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	544761	usd
CY2023	budz	Imputed Interest On Loans ImputedInterestOnLoans	21494	usd
CY2022	budz	Imputed Interest On Loans ImputedInterestOnLoans	31722	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	90000	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	613600	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3228	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-4457	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6214	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-56079	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-223144	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	86085	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1074087	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-812975	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023	budz	Proceeds From Disposal Of Fixed Asset ProceedsFromDisposalOfFixedAsset	1641073	usd
CY2022	budz	Proceeds From Disposal Of Fixed Asset ProceedsFromDisposalOfFixedAsset	1257037	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1631073	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1257037	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	50000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	504000	usd
CY2023	budz	Repayments On Notes Payable Related Party RepaymentsOnNotesPayableRelatedParty	637979	usd
CY2022	budz	Repayments On Notes Payable Related Party RepaymentsOnNotesPayableRelatedParty	585721	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	106946	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-587979	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-148667	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30993	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	295395	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5576	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-777	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315826	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19654	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	290409	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315826	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	980	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	31622	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	budz	Acquistion Of Hemprical Genetics With Common Stock And Note Payable AcquistionOfHempricalGeneticsWithCommonStockAndNotePayable	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1619772	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	108431	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	410942	usd
CY2022	budz	Acquistion Of Hemprical Genetics With Common Stock And Note Payable AcquistionOfHempricalGeneticsWithCommonStockAndNotePayable	603284	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">WEED, Inc. (the “Company”), (formerly United Mines, Inc.) was incorporated under the laws of the State of Arizona on August 20, 1999 (“Inception Date”) as Plae, Inc. to engage in the exploration of gold and silver mining properties. On November 26, 2014, the Company was renamed from United Mines, Inc. to WEED, Inc. and was repurposed to pursue a business involving the purchase of land, and building Commercial Grade “Cultivation Centers” to consult, assist, manage & lease to Licensed Dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company’s plan is to become a True “Seed-to-Sale” company providing infrastructure, financial solutions and real estate options in this new emerging market. The Company, under United Mines, was formerly in the process of acquiring mineral properties or claims located in the State of Arizona, USA. The name was previously changed on February 18, 2005 to King Mines, Inc. and then subsequently changed to United Mines, Inc. on March 30, 2005. The Company trades on the OTC Pink Sheets under the stock symbol: BUDZ.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 20, 2017, the Company acquired Sangre AT, LLC, a Wyoming company doing business as Sangre AgroTech. (“Sangre”). Sangre is a plant genomic research and breeding company comprised of top-echelon scientists with extensive expertise in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry, utilizing the most advanced sequencing and analytical technologies and proprietary bioinformatics data systems available. No work is being conducted now until further funds are available.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 2, 2022, the Company acquired Hempirical Genetics, LLC, a Arizona company. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has a calendar year end for reporting purposes.</p>
CY2023	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying consolidated balance sheet at December 31, 2023, has been derived from audited consolidated financial statements and the audited condensed consolidated financial statements as of December 31, 2023 and 2022 ( the “financial statements”), have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited consolidated financial statements and related footnotes. It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for a fair financial statements presentation. The consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the consolidated financial statements not misleading as required by Regulation S-X, Rule 10-01. Interim result are not necessarily indicative of results for a full year.</p>
CY2023	dei	Parent Entity Legal Name ParentEntityLegalName	WEED, Inc.
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	516340	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1208830	usd
CY2023	us-gaap	Depreciation Depreciation	49791	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	2911	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	14491	usd
CY2023	us-gaap	Payments To Acquire Oil And Gas Property PaymentsToAcquireOilAndGasProperty	41400	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	35800	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5576	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-777	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	624771	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84392563	usd
CY2023Q4	budz	Working Capital Deficit WorkingCapitalDeficit	-328867	usd
CY2023Q4	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	133073	usd
CY2022Q4	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	706507	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	37500	usd
CY2023Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	500000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	182500	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	434750	usd
CY2022	us-gaap	Depreciation Depreciation	106122	usd
CY2022Q2	us-gaap	Goodwill Goodwill	480801	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	480801	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14484	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11884	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	36183	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	38783	usd
CY2023Q4	us-gaap	Goodwill Goodwill	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	36183	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	38783	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2600	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2460	usd
CY2023Q4	budz	Notes Payable Related Parties Classified Current Gross NotesPayableRelatedPartiesClassifiedCurrentGross	157000	usd
CY2022Q4	budz	Notes Payable Related Parties Classified Current Gross NotesPayableRelatedPartiesClassifiedCurrentGross	744979	usd
CY2023Q4	budz	Loan Fee Net Of Amortization LoanFeeNetOfAmortization	23927	usd
CY2022Q4	budz	Loan Fee Net Of Amortization LoanFeeNetOfAmortization	38472	usd
CY2023Q4	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	133073	usd
CY2022Q4	budz	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	706507	usd
CY2023	budz	Imputed Interest On Loans ImputedInterestOnLoans	21494	usd
CY2022	budz	Imputed Interest On Loans ImputedInterestOnLoans	31722	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2023	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	0	usd
CY2022	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	697	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2023	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1200	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	31653	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31653	usd
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023	budz	Common Stock Issued For Stock Payable Shares CommonStockIssuedForStockPayableShares	2072000	shares
CY2023	budz	Common Stock Issued For Stock Payable Value CommonStockIssuedForStockPayableValue	701250	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	300000	shares
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	356250	usd
CY2022	budz	Shares Issued To Salary Included In Subscription Payable SharesIssuedToSalaryIncludedInSubscriptionPayable	25000	shares
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	30577	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1528105	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	17870389	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	30577	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	17900966	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3759203	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3759203	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd

Files In Submission

Name	View Source	Status
0001096906-24-000701-index-headers.html	Edgar Link	pending
0001096906-24-000701-index.html	Edgar Link	pending
0001096906-24-000701.txt	Edgar Link	pending
0001096906-24-000701-xbrl.zip	Edgar Link	pending
budz-20231231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
budz-20231231_cal.xml	Edgar Link	unprocessable
budz-20231231_def.xml	Edgar Link	unprocessable
budz-20231231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
budz-20231231_pre.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
weed-10k.htm	Edgar Link	pending
weed-10kimg3.jpg	Edgar Link	pending
weed_ex311.htm	Edgar Link	pending
weed_ex312.htm	Edgar Link	pending
weed_ex321.htm	Edgar Link	pending
weed_ex322.htm	Edgar Link	pending
weed-10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BUDZ
WEED, INC. Stock $budz

2024 Q1 Form 10-K Financial Statement

#000109690624000701 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUDZ WEED, INC. Stock $budz

2024 Q1 Form 10-K Financial Statement

#000109690624000701 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUDZ
WEED, INC. Stock $budz